Towards Proved Formal Specification and Verification of STL Operators as Synchronous Observers

Authors: Bellanger, Céline, Garoche, Pierre-Loïc, Martel, Matthieu, Picard, Célia

Source: EPTCS 395, 2023, pp. 188-204

Subject Terms: Computer Science - Logic in Computer Science

Access URL: http://arxiv.org/abs/2311.09788

A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics

Authors: Durand, Romane, Descamps, Géraldine, Bellanger, Céline, Dousset, Christelle, Maïga, Sophie, Alberge, Jean-Baptiste, Derrien, Jennifer, Cruard, Jonathan, Minvielle, Stéphane, Lilli, Nicoletta Libera, Godon, Catherine, Le Bris, Yannick, Tessoulin, Benoit, Amiot, Martine, Gomez-Bougie, Patricia, Touzeau, Cyrille, Moreau, Philippe, Chiron, David, Moreau-Aubry, Agnès, Pellat-Deceunynck, Catherine

Source: In Blood 28 March 2024 143(13):1242-1258

CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma

Authors: Decombis, Salomé, Bellanger, Celine, Le Bris, Yannick, Madiot, Candice, Jardine, Jane, Santos, Juliana Carvalho, Boulet, Delphine, Dousset, Christelle, Menard, Audrey, Kervoelen, Charlotte, Douillard, Elise, Moreau, Philippe, Minvielle, Stephane, Moreau-Aubry, Agnes, Tessoulin, Benoit, Roue, Gael, Bidère, Nicolas, Le Gouill, Steven, Pellat-Deceunynck, Catherine, Chiron, David

Source: In Blood 2 November 2023 142(18):1543-1555

p53 regulates CD46 expression and measles virus infection in myeloma cells

Authors: Lok, Anne, Descamps, Geraldine ^*, Tessoulin, Benoit, Chiron, David, Eveillard, Marion, Godon, Catherine, Le Bris, Yannick, Vabret, Astrid, Bellanger, Celine, Maillet, Laurent, Barillé-Nion, Sophie, Gregoire, Marc, Fonteneau, Jean-François, Le Gouill, Steven, Moreau, Philippe, Tangy, Frederic, Amiot, Martine, Moreau-Aubry, Agnes, Pellat-Deceunynck, Catherine ^*

Source: In Blood Advances 11 December 2018 2(23):3492-3505

Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma

Authors: Chiron, David, Bellanger, Céline ^*, Papin, Antonin ^*, Tessoulin, Benoit, Dousset, Christelle, Maiga, Sophie, Moreau, Anne, Esbelin, Julie, Trichet, Valérie, Chen-Kiang, Selina, Moreau, Philippe, Touzeau, Cyrille, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine

Source: In Blood 15 December 2016 128(24):2808-2818

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.

Authors: Malarikova, Diana, Jorda, Radek, Kupcova, Kristyna, Senavova, Jana, Dolnikova, Alexandra, Pokorna, Eva, Kazantsev, Dmitry, Nozickova, Kristina, Sovilj, Dana, Bellanger, Celine, Chiron, David, Andera, Ladislav, Krystof, Vladimir, Strnad, Miroslav, Helman, Karel, Klanova, Magdalena, Trneny, Marek, Havranek, Ondrej, Klener, Pavel

Source: Experimental Hematology & Oncology; 3/25/2024, Vol. 13 Issue 1, p1-4, 4p

Subject Terms: MANTLE cell lymphoma, VENETOCLAX, CYCLIN-dependent kinases, KINASE inhibitors, CYCLINS

STP938, a Selective CTPS1 Inhibitor, Shows Single Agent Activity and Synergy with BCL2 Inhibition in Preclinical Models of Mantle Cell Lymphoma

Authors: Chiron, David ^*, Menoret, Emmanuelle ^*, Kervoelen, Charlotte ^*, Maïga, Sophie ^*, Bellanger, Celine ^*, Tessoulin, Benoit ^*, Touzeau, Cyrille ^*, Asnagli, Hélène ^*, Parker, Andy ^*, Beer, Philip ^*, Pellat-Deceunynck, Catherine

Source: In Blood 15 November 2022 140 Supplement 1:6014-6015

TP53 CRISPR/Cas9 Reveals Strict BAX Dependence in the Response to BH3 Mimetic Targeting MCL1

Authors: Durand, Romane ^*, Costes-Tertrais, Domitille ^*, Descamps, Geraldine ^*, Dousset, Christelle ^*, Maïga, Sophie ^*, Alberge, Jean-Baptiste ^*, Douillard, Elise ^*, Derrien, Jennifer ^*, Bellanger, Celine ^*, Chiron, David ^*, Minvielle, Stephane ^*, Touzeau, Cyrille ^*, Moreau, Philippe ^*, Amiot, Martine ^*, Gomez-Bougie, Patricia ^*, Moreau-Aubry, Agnes ^*, Pellat-Deceunynck, Catherine

Source: In Blood 15 November 2022 140 Supplement 1:4198-4199

CARD11 and BCL2A1 Join Forces to Promote Resistance to Ibrutinib/Venetoclax Combination in Lymphoma Patients

Authors: Decombis, Salomé ^*, Bellanger, Celine ^*, Le Bris, Yannick ^*, Boulet, Delphine ^*, Jardine, Jane ^*, Dousset, Christelle ^*, Ménard, Audrey ^*, Kervoelen, Charlotte ^*, Douillard, Elise ^*, Moreau, Philippe ^*, Minvielle, Stephane ^*, Moreau-Aubry, Agnes ^*, Tessoulin, Benoit ^*, Bidère, Nicolas ^*, Le Gouill, Steven, Pellat-Deceunynck, Catherine, Chiron, David ^*

Source: In Blood 15 November 2022 140 Supplement 1:2044-2045

Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.

Authors: Herviou, Laurie, Ovejero, Sara, Izard, Fanny, Karmous-Gadacha, Ouissem, Gourzones, Claire, Bellanger, Celine, De Smedt, Eva, Ma, Anqi, Vincent, Laure, Cartron, Guillaume, Jin, Jian, De Bruyne, Elke, Grimaud, Charlotte, Julien, Eric, Moreaux, Jérôme

Source: Clinical Epigenetics; 9/16/2021, Vol. 13 Issue 1, p1-18, 18p

Subject Terms: CELL survival, MULTIPLE myeloma, GENETIC mutation, DRUG resistance, CANCER cells, TUMOR suppressor genes, P53 antioncogene

The IL32/BAFF Axis Supports Prosurvival Dialog in the Lymphoma Ecosystem and Is Disrupted By NIK Inhibition

Authors: Decombis, Salome, Papin, Antonin, Bellanger, Celine, Sortais, Clara, Dousset, Christelle, Le Bris, Yannick, Blandin, Stephanie, Hulin, Philippe, Tessoulin, Benoit, Rouel, Mathieu, Le Gouill, Steven, Moreau-Aubry, Agnes, Pellat-Deceunynck, Catherine, Chiron, David

Source: In Blood 23 November 2021 138 Supplement 1:781-781

CSF1R and BTK Inhibitions As Novel Strategies to Disrupt the Dialogue between Mantle Cell Lymphoma and Macrophages

Authors: Papin, Antonin ^*, Tessoulin, Benoit ^*, Bellanger, Céline ^*, Moreau, Anne ^*, LE Bris, Yannick ^*, Maisonneuve, Herve, Moreau, Philippe ^*, Touzeau, Cyrille ^*, Amiot, Martine ^*, Pellat-Deceunynck, Catherine, Le Gouill, Steven ^*, Chiron, David ^*

Source: In Blood 29 November 2018 132 Supplement 1:2855-2855

This result is not displayed to guests.
Login for full access.